4Hochberg MC. Updating the American College of Rhe-umatology revised criteria for the classification of sys-temic lupus erythematosusCJ]. Arthritis Rheum, 1997 ,40(9):1 725.
5Mehta RL,Kellum J A, Shah SV,et al. Acute Kidney In-jury Network: report of an initiative to improve out-comes in acute kidney injury [J]. Crit Care,2007,11(2):R31.
6Bombardier C,Gladman DD,Urowitz MB,et al. Deriva-tion of the SLEDAI. A disease activity index for lupuspatients. The Committee on Prognosis Studies in SLE[J]. Arthritis Rheum,1992 ,35(6) ;630-640.
7Wyatt RJ,Emancipator SN,Kon V, et al. IgA nephrop-athy databank: development of a system for manage-ment of renal biopsy acquired data [ J]. Am J KidneyDis, 1997,29(6) :817-828.
8Cohen D,Koopmans M, Kremer HI, et al. Potential forglomerular C4d as an indicator of thrombotic microan-giopathy in lupus nephritis[J]. Arthritis Rheum, 2008 ,58(8):2 460-2 469.
9Austin HR, Boumpas DT, Vaughan EM, et al. High-risk features of lupus nephritis: importance of race andclinical and histological factors in 166 patients [J].Nephrol Dial Transplant, 1995^10(9) :1 620-1 628.
10Hsieh YP, Wen YK’Chen ML. The value of early renalbiopsy in systemic lupus erythematosus patients pres-enting with renal involvement[J]. Clin Nephrol,2012,77(1):18-24.
